Metrad Biosystems

🗓 Founded 2012💰 Last funded 1988
Biotechnology Research
LinkedIn
Metrad Biosystems Inc. is developing patented technology to recreate the barrier between the cerebrospinal fluid and the brain, on a cellular level. We are utilizing an interdisciplinary approach blending biomedical engineering and neuroscience, yielding a tool with heretofore unseen capability to study neurodegenerative and congenital neurologic disorders.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Metrad Biosystems?
Metrad Biosystems has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Metrad Biosystems last raise funding?
The most recent investment in Metrad Biosystems recorded on gritt.io was in 1988.
When was Metrad Biosystems founded?
Metrad Biosystems was founded in 2012.
What industry is Metrad Biosystems in?
Metrad Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.